Health Care: Drugs

ARIAD Pharmaceuticals Inc (ARIA: NASDAQ)

$8.1 1.12 | 16.05%
08/28/15 - 01:51 PM ET
Company Profile
Price and Volume
Recent Price 6.98
52 Week High 9.89
52 Week Low 4.90
Avg. Daily Vol. (Mil) 3.06
Beta (3 year) 1.58
Share Related Items
Mkt Cap (Mil) 1,318.50
Shares Out (Mil) 188.90
Float (Mil) 169.78
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.20
Current Ratio 3.30
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 9.79
Price/Book 0.00
Price/Cash Flow -8.20
Per Share Data
Earnings -0.91
Sales 0.71
Book Value 0.00
Cash Flow -0.85
Business Summary
ARIAD Pharmaceuticals Inc is an oncology company. The Company is engaged in transforming the lives of cancer patients with breakthrough medicines. It commercializes & develops products and product candidates including Iclusig, Brigatinib, and AP32788.
General Information
26 Landsdowne Street
Cambridge, MA 02139-4234
www.ariad.com
Industry : Drugs
Sector: Health Care
Employees: 379
CEO: Dr. Harvey J. Berger,M.D
Short Interest
Current Month (Mil) 46.70
Previous Month (Mil) 43.84
Short Interest Ratio (Days) 13.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -31.60
Return on Investments -47.80
Profitability
Gross Margin 98.00
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ARIA

Latest ARIA Headlines from TheStreet

More Financial News for ARIA

Press Releases for ARIA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter